Medical News: FDA Says No to Weight-Loss Combo Drug - in Primary Care, Obesity from MedPage Today
Links shared publicly online about this topic.
- 538total visits
Medical News: FDA Says No to Weight-Loss Combo Drug - in Primary Care, Obesity from MedPage Today
View full resource at medpagetoday.com
Tags: Obesity Medication, Antidepressant, Drug, Smoking Cessation Medication, FDA, Contrave
Most Recently Shared on February 1, 2011 at 5:39 pm By:
FDA Says No to Weight-Loss Combo Drug, Contrave, which consists of bupropion and naltrexone. http://bit.ly/g6SOkp
Medical News: Patients Lose Weight With Rejected Combo Pill - in Primary Care, Obesity from MedPage Today
medpagetoday.com — “A combination drug denied FDA approval for treating obesity led to significantly better weight loss compared with placebo, according to a large phase III clinical trial.” View full resource at medpagetoday.com
Most Recently Shared on April 11, 2011 at 12:42 am By:
Patients Lose Weight With Rejected Combo Pill (CME/CE): (MedPage Today) -- A combination drug… http://goo.gl/fb/9UbFy
Medical News: FDA Says No to Weight-Loss Combo Drug - in Primary Care, Obesity from MedPage Today
medpagetoday.com — “A pill combining bupropion and naltrexone for weight loss (Contrave) won't receive the FDA's approval until its manufacturer, Orexigen, conducts a new clinical trial evaluating its cardiovascular risk” View full resource at medpagetoday.com
Most Recently Shared on February 1, 2011 at 5:50 pm By:
FDA Says No to Weight-Loss Combo Drug http://bit.ly/hL8N7y
Medical News: FDA Says No to Weight-Loss Combo Drug - in Primary Care, Obesity from MedPage Today
medpagetoday.com — “A pill combining bupropion and naltrexone for weight loss (Contrave) won't receive the FDA's approval until its manufacturer, Orexigen, conducts a new clinical trial evaluating its cardiovascular risk” View full resource at medpagetoday.com
Most Recently Shared on February 1, 2011 at 5:13 pm By:
FDA says no to weight-loss combo drug: http://bit.ly/eTFDFC
Advertisement
